ID   BL-92
AC   CVCL_ZI24
SY   BL92; BL 92; BL 092; IARC/BL92; IARC-BL92; IARC BL92; IARC BL 92
DR   Wikidata; Q98125587
RX   PubMed=11793449;
RX   PubMed=24590883;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Virology: EBV-negative.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZJ33 ! IARC-503
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 5
//
RX   PubMed=11793449; DOI=10.1002/gcc.10022;
RA   Sobol H., Benziane A., Kerangueven F., Yin L., Noguchi T., Pauly S.,
RA   Eisinger F., Longy M., Romeo G., Lenoir G.M., Birnbaum D.;
RT   "Genome-wide search for loss of heterozygosity in Burkitt lymphoma
RT   cell lines.";
RL   Genes Chromosomes Cancer 33:217-224(2002).
//
RX   PubMed=24590883; DOI=10.1002/gcc.22161;
RA   Murga Penas E.-M., Schilling G., Behrmann P., Klokow M.,
RA   Vettorazzi E., Bokemeyer C., Dierlamm J.;
RT   "Comprehensive cytogenetic and molecular cytogenetic analysis of 44
RT   Burkitt lymphoma cell lines: secondary chromosomal changes
RT   characterization, karyotypic evolution, and comparison with primary
RT   samples.";
RL   Genes Chromosomes Cancer 53:497-515(2014).
//